Race against time: which IV fluid saves more sepsis patients?
NCT ID NCT07240701
Summary
This study aims to find out if one common IV fluid is better than another for the initial emergency treatment of sepsis, a life-threatening infection response. Researchers will compare Ringer's lactate solution to normal saline in 88 adult patients to see which fluid leads to better survival and recovery in the first 24 hours. This is a Phase 4 trial, meaning it's testing already-approved fluids in a real-world hospital setting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kutahya City Hospital
Kütahya, 43100, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.